COMMUNIQUÉS West-GlobeNewswire

Streamline Health® Reports Fiscal Third Quarter 2024 Financial Results, Accelerates Anticipated Adjusted EBITDA Breakeven Timeline
16/12/2024
Net loss of ($2.5 million) during the third quarter of fiscal 2024 compared to a net loss of ($11.9 million) during the third quarter of fiscal 2023 Company reiterated $15.5 million implemented SaaS ARR adjusted EBITDA [...]
Regeneron Named to Dow Jones Sustainability World Index for Sixth Consecutive Year
16/12/2024
TARRYTOWN, N.Y., Dec. 16, 2024 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced its sixth consecutive inclusion in the Dow Jones Sustainability World Index (DJSI World) and fifth [...]
Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
16/12/2024
MALVERN, Pa., Dec. 16, 2024 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM) (the “Company”) today announced the granting of inducement awards to new employees as described below. In accordance with NASDAQ Listing [...]
Tenaya Therapeutics to Announce Initial Data from MyPEAK-1 Phase 1b/2 Clinical Trial of TN-201 Gene Therapy for MYBPC3-Associated Hypertrophic Cardiomyopathy on Tuesday, December 17, 2024
16/12/2024
Company to host conference call on Tuesday, December 17, at 8:00 a.m. ET SOUTH SAN FRANCISCO, Calif., Dec. 16, 2024 (GLOBE NEWSWIRE) -- Tenaya Therapeutics, Inc. (NASDAQ: TNYA), a clinical-stage biotechnology company [...]
Enzo Biochem Reports First Quarter Fiscal Year 2025 Results and Provides a Company Update
16/12/2024
FARMINGDALE, N.Y., Dec. 16, 2024 (GLOBE NEWSWIRE) -- Enzo Biochem, Inc. (NYSE: ENZ) (“Enzo” or the “Company”) today announced financial results for the fiscal first quarter ended October 31, 2024. First Quarter [...]
HeartSciences Provides Business Update and Reports Second Quarter Fiscal 2025 Financial Results
16/12/2024
Southlake, TX, Dec. 16, 2024 (GLOBE NEWSWIRE) -- HeartSciences Inc. (Nasdaq: HSCS; HSCSW) ("HeartSciences" or the "Company") , an artificial intelligence (AI)-powered medical technology company focused on transforming [...]
Annexon Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(c)(4)
16/12/2024
BRISBANE, Calif., Dec. 16, 2024 (GLOBE NEWSWIRE) -- Annexon, Inc. (Nasdaq: ANNX), a biopharmaceutical company advancing a late-stage clinical platform of novel therapies for people living with devastating classical [...]
Bionomics Announces Supreme Court of New South Wales Approves Bionomics’ Re-Domiciliation
16/12/2024
ADELAIDE, Australia, and CAMBRIDGE, Mass., Dec. 16, 2024 (GLOBE NEWSWIRE) -- Bionomics Limited (Nasdaq: BNOX) (Bionomics or Company) is pleased to announce that the Supreme Court of New South Wales, Australia (“Court”) [...]
CG Oncology Announces Closing of Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
16/12/2024
IRVINE, Calif., Dec. 16, 2024 (GLOBE NEWSWIRE) -- CG Oncology, Inc. (Nasdaq: CGON), a late-stage clinical biopharmaceutical company focused on developing and commercializing a potential backbone bladder-sparing [...]
Merus announces First Patient Dosed in Phase 2 Trial of Petosemtamab in 3L+ mCRC
16/12/2024
UTRECHT, The Netherlands and CAMBRIDGE, Mass., Dec. 16, 2024 (GLOBE NEWSWIRE) -- Merus N.V . (Nasdaq: MRUS), a clinical-stage oncology company developing innovative, full-length multispecific antibodies (Biclonics ® and [...]
Candel Therapeutics Announces Closing of Public Offering and Full Exercise of the Underwriters' Option to Purchase Additional Shares
16/12/2024
NEEDHAM, Mass., Dec. 16, 2024 (GLOBE NEWSWIRE) -- Candel Therapeutics, Inc. (“Candel”) (Nasdaq: CADL), a clinical stage biopharmaceutical company focused on developing multimodal biological immunotherapies to help [...]
Merit Medical Announces Resignation of President, Joseph Wright
16/12/2024
SOUTH JORDAN, Utah, Dec. 16, 2024 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI) (“Merit” or the “Company”), a global leader of healthcare technology, today announced the resignation of its President, [...]
Vaso Corporation CEO Reflects on a Year of Growth and Innovation in End-of-Year Letter Setting the Tone for a Promising 2025
16/12/2024
Vaso Corporation 137 Commercial Street Plainview, New York 11803 Tel: (516) 997-4600 Fax: (516) 997-2299 NEWS RELEASE PLAINVIEW, N.Y., Dec. 16, 2024 (GLOBE NEWSWIRE) -- Vaso Corporation (“Vaso”) (OTCQX: VASO), a leader [...]
BioPorto commences process to appoint new Chair of the Board of Directors
16/12/2024
December 16, 2024 Announcement no. 23 BioPorto commences process to appoint new Chair of the Board of Directors COPENHAGEN, DENMARK, December 16, 2024 (GLOBE NEWSWIRE) – The Board of Directors of BioPorto A/S (BioPorto [...]
Alzheimer Society of Ontario Marks an Important Legislative Session for Dementia Care
16/12/2024
TORONTO, Dec. 16, 2024 (GLOBE NEWSWIRE) -- The Alzheimer Society of Ontario would like to congratulate the government on an important legislative term that has placed a strong focus on dementia care. We are encouraged [...]
La Société Alzheimer de l'Ontario souligne une séance législative importante pour les soins liés aux troubles neurocognitifs
16/12/2024
TORONTO, 16 déc. 2024 (GLOBE NEWSWIRE) -- La Société Alzheimer de l’Ontario souhaite saluer le gouvernement pour un mandat législatif important qui a placé un fort accent sur les soins liés aux troubles neurocognitifs. [...]
FOXO TECHNOLOGIES INC. ANNOUNCES THAT STOCKHOLDERS EQUITY IS GREATER THAN $4M, WHICH IS REQUIRED TO MEET THE CONTINUED LISTING REQUIREMENTS OF THE NYSE AMERICAN EXCHANGE
16/12/2024
MINNEAPOLIS, MN, Dec. 16, 2024 (GLOBE NEWSWIRE) -- FOXO Technologies Inc. (NYSE American: FOXO) (the “Company” or “FOXO”) announces that recent transactions have led to the Company having stockholders equity greater [...]
Legend Senior Living Names Rebecca Butler as Vice President of Marketing and Brand Strategy
16/12/2024
WICHITA, Kan., Dec. 16, 2024 (GLOBE NEWSWIRE) -- Legend Senior Living, a senior living owner/operator based in Wichita, KS, has announced Rebecca Butler as its new Vice President of Marketing and Brand Strategy. Butler [...]
Cannara Provides Update on Its 2024 Annual General Meeting Materials amid Canada Post Strike
16/12/2024
MONTREAL, Dec. 16, 2024 (GLOBE NEWSWIRE) -- Cannara Biotech Inc. (“ Cannara ”, “the Company ”, “ us ” or “ we ”) ( TSXV: LOVE ) ( OTCQB: LOVFF ) ( FRA: 8CB0 ), a vertically integrated producer of premium-grade cannabis [...]

Pages